Your session is about to expire
← Back to Search
Varespladib Methyl for Snake Bites (BRAVO Trial)
BRAVO Trial Summary
This trial is testing a new drug to see if it's safe and effective for people who have been bitten by venomous snakes.
- Snake Bites
- Poisoning
BRAVO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BRAVO Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still available for the clinical trial?
"Yes, records from clinicaltrials.gov affirm that enrollment for this research trial is still open. The posting was published on the 15th of August 2021 and modified 3 days later; 110 people are planned to be recruited at 8 different locations."
Has Varespladib Methyl been subjected to any other clinical examinations?
"Varespladib Methyl was initially trialled in 2021 at Westchester Research Center, part of the Westchester General Hospital. 18332 studies have been finalized since then and 2 clinical trials are currently recruiting participants, most notably within Lexington, Kentucky."
How many locations are conducting this experiment?
"The trial is currently enrolling patients from 8 different medical centres, including the University of Kentucky Chandler Medical Center in Lexington, the University of Mississippi Medical Center - Jackson in Jackson, and Loma Linda University Medical Centre in Loma Linda."
Is this clinical trial a pioneering endeavor?
"Scientific research into Varespladib Methyl began in 2021, when Ophirex Inc. sponsored a trial with 18 participants. After successful completion of this initial test, Phase 2 approval was granted in the same year. At present time there are two active trials for Varespladib Methyl taking place across 21 cities and two nations."
What is the participant enrolment rate for this experiment?
"Affirmative. Clinicaltrials.gov data affirms that this clinical trial is actively seeking participants, having been initially posted on August 15th 2021 and last updated 8/18/2022. The study has a target enrolment of 110 patients from 8 medical sites."
What safety measures have been taken regarding the administration of Varespladib Methyl?
"Although Varespladib Methyl has not been trialled to demonstrate efficacy, there is some evidence suggesting its safety and thus it was assigned a rating of 2."
Share this study with friends
Copy Link
Messenger